Palivizumab Prophylaxis among Infants at Increased Risk of Hospitalization due to Respiratory Syncytial Virus Infection in UAE: A Hospital-Based Study

<div>Flow diagram of the study participants and outcomes (gestational age subgroups). RSV, respiratory syncytial virus.</div>

Canadian Respiratory Journal

fig1

Figure 1

Figure 1: Palivizumab Prophylaxis among Infants at Increased Risk of Hospitalization due to Respiratory Syncytial Virus Infection in UAE: A Hospital-Based Study 

Figure 1 | Palivizumab Prophylaxis among Infants at Increased Risk of Hospitalization due to Respiratory Syncytial Virus Infection in UAE: A Hospital-Based Study 